Try our Advanced Search for more refined results

Expert Analysis

FTC Orange Book Move Signals New Pharma Patent Scrutiny

By Steve Albertson, Carl Morales and Erica Sutter ( November 17, 2023, 3:44 PM EST) -- On Nov. 7, the Federal Trade Commission announced it is disputing the listing of more than 100 patents in the U.S. Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations, known as the Orange Book.[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!